Researcher

Hao Chen

Shanghai Cancer Institute

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 5, 2026 · JOURNAL ARTICLE

Efficacy and Safety of DVDMS ‐Photodynamic Therapy for Dysphagia in Advanced Esophageal Cancer: A Phase II Clinical Trial

Cancer Science

Phase II trial with modest sample size showing acceptable safety profile and 40% response rate for dysphagia in advanced esophageal cancer, but requires larger confirmatory studies before clinical adoption.

PromisingShegan Gao Yongqian Shu Hao Chen

Reported

Overall response rate (esophageal)40.0%

Median overall survival9.51 months

95% CI for median OS5.45–NE

AUG 17, 2026 · JOURNAL ARTICLE

F7 Drives Gastric Cancer Metastasis Through Anoikis Resistance and Tumor Microenvironment Remodeling

Advanced Science

Mechanistic study identifying F7 as a driver of gastric cancer metastasis through cell signaling and microenvironment remodeling, with a potential therapeutic compound tested in model systems but no clinical efficacy data reported.

Hypothesis-GeneratingHao Chen Bofang Wang Yunpeng Wang

Study details

InterventionF7 signaling pathway interrogation; Thonnin…